6
Patients monitored
3
Patients surfaced
1
Cross-indication patients
5
Opportunities surfaced
Margaret Chen
58 y · female · BMI 32 · Type 2 Diabetes
Meds: Metformin, Atorvastatin
cross-indication Cardiology Sleep Endocrinology
Est. AHI
35/h
18/28 nights flagged for breathing disturbances; 18 nights with SpO₂ nadir < 90%
AFib burden
25%
7 day(s) with irregular-rhythm alerts, 3 ECG classified AFib over 28 monitored days
Hypoxemia idx
64%
18/28 nights below 90% SpO₂ (overnight nadir)
Resting HR
+8 bpm
rising trend
HRV (SDNN)
-12 ms
falling trend
Hypertension
none
No hypertension notifications
Live trial matches· ClinicalTrials.gov
No currently-recruiting trial matched this patient's signals — the radar stays quiet.
Clinical rationale
Evidence chain
Click an opportunity to highlight the wearable signals it traces back to.
Wearable signals · 28 days
Resting heart rate
74 bpmHeart-rate variability (SDNN)
30 msOxygen saturation (overnight nadir)
88.3 %Respiratory rate
16.8 br/minEvent timeline · 28 days
05-09 → 06-05Irregular rhythm
6
ECG → AFib
3
Apnea notification
18
SpO₂ < 90%
18